Abstract:
Lymphatic filariasis (LF), one of the major causes of chronic disability in the
developing countries produces a considerable economic burden. Globally, around
1100 million people in 80 countries are at risk and 118 million people show clinical
manifestations. It is caused by the nematode parasites Wuchereria bancrofti, Brugia
malayi and B. timori. Current estimate shows that in India about 553 million people
live in endemic areas with approximately 48 million have either circulating
Microfilariae (Mf) or overt disease like hydrocele, lymphoedema and elephantiasis [1,
2]. Around 50% of the infected persons suffer from acute episodic attacks of
adenolymphangitis (ADL) and fever. A million individuals have cryptic infections
resulting in conditions such as tropical pulmonary eosinophilia (TPE). The infection
is transmitted by mosquitoes (W. bancrofti by Culex quinquefasciatus and B. malayi
by Mansonia sp.). The infection is initiated by introduction of third stage infective
larvae (L3) of the parasite into the host by the bites of L3-bearing mosquitoes.
Adults parasites reside into the lymphatics and Mf circulate and available in the
peripheral blood.
The parasites survive for several years in mammalian hosts, often without
causing overt clinical manifestations. At initial stage the disease is characterized by
acute episodes of adenolymphangitis, fever and associated constitutional
symptoms. The recurrent episodic bouts of acute manifestations occurring over a
period of time lead to the development of chronic disease manifestations such as
elephantiasis, lymphedema and/ or hydrocoele. It is believed that the presence of
adult worms in lymphatics results in dilation of the vessels, and this is considered to
be the primary reason that predisposes to disease manifestations because of
chronic exposure of inflammatory elements.
Filarial parasites present a diverse array of antigens possessing both
suppressive and stimulatory type and therefore the host response against these
antigens is expected to be complex and variable. However, precise identity of the
molecules and how the molecules are involved in the host-parasite interactions and
their outcome in relation to protection of host from infection or protection for the
parasites or infection-induced manifestations is unresolved. The pre-requisite to achieve this is the identification of parasite molecules that are responsible for
initiating such reaction. The next logical step is delineation of the immune mediated
responses to the parasite molecules. Proinflammatory mediators, like proinflammatory
cytokines, nitric oxide (NO) etc are known to have a direct implication
in the protection and pathology of LF.
Nitric oxide (NO) is a multi-faceted molecule with dichotomous regulatory
roles in many areas of biology including as a toxic defense molecule against
infectious organisms. It is a highly reactive and pervasive biological mediator
produced by mammalian cells, and its physiological actions are broad. NO mediated
functions fall into three categories: (1) smooth muscle relaxation [3, 4], (2)
neurotransmission [5] and (3) cell mediated immune response [6, 7]. It also regulates
the functional activity, growth and death of many immune and inflammatory cell
types including macrophages, T lymphocytes, antigen-presenting cells, mast cells,
neutrophils and natural killer cells [8]. However, the role of NO in nonspecific and
specific immunity in vivo and in immunologically mediated diseases and
inflammation like filariasis is poorly understood.
NO does not act through a receptor—its target cell specificity depends on its
concentration, its chemical reactivity, the vicinity of target cells and the way that
target cells are programmed to respond. At high concentration as generated by
NOS-2, NO is rapidly oxidized to reactive nitrogen oxide species (RNOS) that
mediate most of the immunological effects. RNOS can S-nitrosate thiols to modify
key signaling molecules such as kinases and transcription factors. Several key
enzymes in mitochondrial respiration are also inhibited by RNOS and this leads to a
depletion of ATP and cellular energy. A combination of these interactions may lead
to the multiple actions of NO in the regulation of immune and inflammatory cells.
Because the immune system is activated in response to infection, any associated
NO response would develop in parallel, over days or weeks rather than within a
fraction of a second as in physiological responses. Also, for NO to be effective as a
toxic or immune regulatory mediator it needs to be generated at high levels for a
sustained period of time. NO exerts immunosuppressive effects in vivo also since in
NOS-2 gene knockout mice Th1 responses have been shown be enhanced to
Leishmania infection [9] and implicated in exacerbated severity of autoimmune encephalitis [10]. In addition, NO regulates death of immune cells, either through
induction or inhibition of apoptosis, or by necrosis. In some cell types NO can
promote apoptosis, whereas in other cells NO inhibits apoptosis. High NO
concentrations lead to the formation of toxic reaction products like dinitrogen
trioxide or peroxynitrite that induce cell death, if not by apoptosis, then by necrosis. Long-term exposure to nitric oxide in certain conditions like chronic
inflammatory states may predispose cells to tumorigenesis through DNA damage,
inhibition of DNA repair, alteration in programmed cell death, or activation of
proliferative signaling pathways. In filariasis these phenomenon is not clear.
Cytokines are potent messenger molecules at sites of inflammation. Parasiteinduced
cytokines, such as IFN-γ, TNF-α, IL-1β, and pathogen products such as
glycosylphosphatidylinositols, can stimulate iNOS expression in infected hosts [11-13]
(Figure). In other words, agents that induce iNOS expression include various
proinflammatory cytokines (IL-1β, TNF-α- and IFN-γ), endotoxin lipopolysaccharide
(LPS) and other agents [14]. The specific relationship among IL-1β, TNF-α- and IFN-γ
on iNOS induction and NO synthesis in cells has not been reported in filariasis. In
addition synergistic action between NO and cytokines is not clear in filariasis. Earlier
study carried out in this laboratory revealed that level of IFN-γ and NO increased after L3 exposure to animals immunized with predominantly proinflammatory
cytokine stimulating fraction of B. malayi which was found implicated in suppressing
L3-induced filarial infection [15]. Thus, these reports encourage us to study
synergistic or direct or indirect effects of proinflammatory cytokines on the NO
expression.
In nature, both endemic normals and chronic filarial patients, who are
considered immune to L3 invasion or adult worms, have shown to have higher IFN-γ
levels [16, 17]. Further, investigators have also demonstrated increased level of IFN-γ
and IL-2 in endemic normal individuals and suggested that type 1 inflammatory
responses may be involved in killing of L3 stage of the parasite and could be the
mechanism by which endemic normals remain infection free. Das et al. (1996) [18]
have reported that proinflammatory cytokines particularly TNF-α was raised during
acute episodic attacks in filariasis but whether NO is also raised during this period
and relationship between the two is not clear. In filariasis, NO mediated
mechanisms have been shown to be capable of killing Mf in vitro and L3 in vivo and
protect the host through Type 1 responses and IFN-γ stimulated toxic mediator’s
release [19-21]. iNOS gene expression is regulated by complex mechanisms.
Studies carried out in this laboratory have shown that BmAFII, a Sephadex
G-200 eluted fraction of B. malayi adult worm extract, with molecules ranging from
21 to 84kDa, protected the host against B. malayi in M. coucha [15] and cross
protected Leishmania donovani infection in hamsters [22] by stimulating
predominantly proinflammatory responses. Further, SDS - PAGE fractions of the
parasite corresponding to the molecular weight range of BmAFII were able to
stimulate pro- and anti-inflammatory cytokines release in vitro [23]. Of these F6
(67.8-54.35 kDa) revealed that it protected the host from the parasite via Th1/Th2
type responses. A ~62kDa molecule of B. malayi suppressed the establishment of
L3-induced infection in M. coucha and this correlated well with enhanced IFN-γ
release, DNA damage in lymphocytes and downregulation of IL-10. These findings
have provided leads for exploring whether some of the parasite molecules may also
stimulate NO. The present study was therefore aimed for identifying and
characterizing NO-stimulating molecules and to determine their role in protecting the host from infection. The present study was therefore undertaken with the
following
Objectives:
1. Identification, isolation and purification of NO stimulating fractions of
B. malayi adult worm.
2. To investigate effect of the identified fraction(s) on the development
and establishment of B. malayi L3 induced infection in M. coucha.
3. To investigate immunogenicity of the fraction(s).
4. To resolve proteins of the fraction(s) by 2DE and identify them by
MALDI-TOF-MS.
5. To investigate role of identified fraction(s) in apoptosis.
6. Expression of NO genes in response to identified fraction(s) under Th1
/Th2 cytokine milieu.